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Abstract
A total of 1623 clinical isolates of Salmonella belonging to 229 serotypes were received by the Senegalese Reference Center for
Enterobacteria from January 1999 to December 2009. The most common serotypes were Enteritidis (19% of the isolates), Typhi (8%),
Typhimurium (7%) and Kentucky (4%). A signiﬁcant increase in the prevalence of resistance to amoxicillin (0.9% in 1999 to 11.1% in 2009)
and nalidixic acid (0.9% in 1999 to 26.7% in 2009) was observed in non-typhoidal Salmonella serotypes. For critically important antibiotics,
notably ciproﬂoxacin and extended-spectrum cephalosporins (ESCs), the rates of resistance were low: 0.3% and 0.5%, respectively. Seven
ESC-resistant Salmonella strains and three additional ESC-resistant strains from Senegal (1990) and Mali (2007) were studied to identify the
genetic basis of their antibiotic resistance. All ESC-resistant strains produced an extended-spectrum b-lactamase (ESBL). These were
CTX-M-15 (n = 6; 2000–2008), SHV-12 (n = 3; 2000–2001) and SHV-2 (n = 1; 1990). A large IncHI2 ST1 pK29-like plasmid was found in
six strains (three producing SHV-12 and three CTX-M-15), whereas IncN and IncF plasmids were found in three strains and one strain,
respectively. The association of plasmid-mediated quinolone resistance (PMQR) genes qnrB1 and aac(6′)-Ib-cr was found in four
ESBL-producing strains, leading to decreased susceptibility and even full resistance to ciproﬂoxacin (MIC range 0.75–2 mg/L) despite the
absence of mutations in the quinolone resistance-determining region (QRDR) of gyrA, gyrB, parC and parE. This association of ESBL and
multiple PMQR mechanisms within the same strains is therefore a serious concern as it hampers the use of both ESCs and ﬂuoroquinolones
for severe Salmonella infections.
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Abstract
Infections due to carbapenem-resistant Klebsiella pneumoniae (CR-KP) have emerged as a public health problem worldwide given their
spread dynamics and the limited therapeutic options. Our aim was to study the clinical outcome of patients with CR-KP infections in
relation to antimicrobial treatment. CR-KP infections that occurred in a 10-month period (September 2009 to June 2010) in patients
admitted to 19 intensive care units all over Greece were studied. A total of 127 CR-KP infections were reported. Central venous catheter
bacteraemia was the most frequent infection, followed by ventilator-associated pneumonia (39 (30.7%) and 35 (27.6%) cases, respectively).
Resistance to colistin, tigecycline, gentamicin and amikacin was detected in 20%, 33%, 21% and 64% of isolates, respectively. Regarding
treatment, 107 cases received active treatment, including 1 or ≥2 active antibiotics in 65 (60.7%) and 42 (39.3%) cases, respectively. The
most frequent combination was colistin plus aminoglycoside and tigecycline plus aminoglycoside (17 and 11 cases, respectively). Forty-eight
(45.2%) of the cases that received active treatment were considered clinical failures, with 23.5% mortality at 14 days. Logistic regression
analysis revealed that age ≤55 years, non-immunocompromised patients and patients who received colistin had higher successful response
rates, while patients ≤55 years old had lower mortality rates at 14 days after the introduction of active treatment. CR-KP infections are
associated with a signiﬁcant clinical failure rate. Colistin remains a valuable antimicrobial agent for treating these infections, while the rise of
resistance to the last available antibiotics further limits treatment options.
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Abstract
The EMRSA-15 clone is a major cause of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK and elsewhere
but existing typing methodologies have limited capacity to discriminate closely related strains, and are often poorly reproducible between
laboratories. Here, we report the design, development and validation of a genome-wide single nucleotide polymorphism (SNP) typing
method and compare it to established methods for typing of EMRSA-15. In order to identify discriminatory SNPs, the genomes of 17
EMRSA-15 strains, selected to represent the breadth of genotypic and phenotypic diversity of EMRSA-15 isolates in Scotland, were
determined and phylogenetic reconstruction was carried out. In addition to 17 phylogenetically informative SNPs, ﬁve binary markers were
included to form the basis of an EMRSA-15 genotyping assay. The SNP-based typing assay was as discriminatory as pulsed-ﬁeld gel
electrophoresis, and signiﬁcantly more discriminatory than staphylococcal protein A (spa) typing for typing of a representative panel of
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diverse EMRSA-15 strains, isolates from two EMRSA-15 hospital outbreak investigations, and a panel of bacteraemia isolates obtained in
healthcare facilities in the east of Scotland during a 12-month period. The assay is a rapid, and reproducible approach for epidemiological
analysis of EMRSA-15 clinical isolates in Scotland. Unlike established methods the DNA sequence-based method is ideally suited for
inter-laboratory comparison of identiﬁed genotypes, and its ﬂexibility lends itself to supplementation with additional SNPs or markers for
the identiﬁcation of novel S. aureus strains in other regions of the world.
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